Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page

Home > What's New > Past Science Meetings    

Blending Clinical Practice and Research: Forging Partnerships to Enhance Drug Addiction Treatment

Speaker Biographies

Loretta P. Finnegan, M.D.
Medical Advisor for the Director
Office of Research on Women's Health
Office of the Director
National Institutes of Health
Room 201
MSC 0161
1 Center Drive
Bethesda, MD 20892-0161
(301) 402-1770
(301) 402-1798 Fax

Dr. Finnegan is Medical Advisor for the Director, Office of Research on Women's Health, National Institutes of Health (NIH), and former Director, Community Prevention Study and Community Outreach of the Women's Health Initiative, National Heart, Lung, and Blood Institute, NIH. After premedical studies at Ursinus College, she obtained her medical degree and completed a pediatric internship at Hahnemann University in Philadelphia. Dr. Finnegan's completed a pediatric residency and neonatal fellowship at Philadelphia General Hospital. Previous positions in Philadelphia include Chief of Newborn Services, University of Pennsylvania Division, Philadelphia General Hospital; Director of the Family Center, a comprehensive, multidisciplinary program for pregnant addicted women and their children, Thomas Jefferson University Hospital; and Professor of Pediatrics, Psychiatry and Human Behavior, Jefferson Medical College, Thomas Jefferson University. Her Federal Government positions in the Department of Health and Human Services include Associate Director of the Office for Treatment Improvement and Associate Director for Medical and Clinical Affairs, Office for Substance Abuse Prevention, Alcohol, Drug Abuse and Mental Health Administration; Senior Advisor on Women's Issues, NIDA, NIH; and Director, Women's Health Initiative, Office of the Director, NIH. Dr. Finnegan has authored more than 150 scientific publications, has spoken on topics related to the health issues of women and children at various scientific conferences, has been a visiting professor in 18 foreign countries, and has served as a consultant to many scientific, Federal, and lay organizations. She has received numerous Federal, State, local, and foundation grants to accomplish her research endeavors. Dr. Finnegan also has received numerous awards for outstanding achievements in the treatment, research, and prevention of drug abuse; for superior achievement in expanding the therapeutic capabilities of the health professions; for excellence in the healing arts; as an outstanding woman who has "made a difference" through her leadership in health care and for her distinguished contributions to humanity; for outstanding leadership and dedication to the alcohol and other drug fields, in recognition for outstanding leadership in development of the violence against women initiative; for outstanding interagency collaboration and innovation in developing the Women Living Long, Living Well Project; and for the advancement of knowledge about alcoholism and other drug dependencies. She has been awarded three honorary degrees: Doctor of Laws (Chestnut Hill College), Doctor of Science (Ursinus College), and Doctor of Science in Osteopathy (University of New England).

<< Back

John Fitzgerald, CPP
Coordinator of Training
Substance Abuse Prevention Program
New York City Board of Education
Room 525
110 Livingston Street
Brooklyn, NY 11201
(718) 935-3245
(718) 935-3198 Fax

Mr. Fitzgerald is Coordinator of Training for the New York City Board of Education's Substance Abuse Prevention Program. He also administers the Safe and Drug-Free Schools money for New York City's nonpublic schools. Mr. Fitzgerald has disseminated, explained, and advanced current research on prevention and early intervention to the approximately 800 substance abuse prevention and intervention specialists who provide prevention services to more than 1 million individuals in the New York City school system. He was President of the New York State Association of Drug and Alcohol Abuse Prevention Professionals, is a member of the board of directors of the Institute of Professional Development in Addictions of New York State, is an associate of the Center for Substance Abuse Prevention's Northeast Center for the Application of Prevention Technologies Program, and is a member of the New York State Prevention Credentials Board. Mr. Fitzgerald contributes to the "Seasons of Peace" child abuse prevention curriculum and writes for New York City's Board of Education Substance Abuse in-service course.

<< Back

Paul J. Fudala, Ph.D.
Clinical Toxicologist
Philadelphia Veterans Affairs Medical Center
Research Associate Professor of Pharmacology in Psychiatry
Behavioral Health Service
University of Pennsylvania School of Medicine
Ward 7, East
University and Woodland Avenues
Philadelphia, PA 19104
(215) 823-6377
(215) 823-5919 Fax

Dr. Fudala received his pharmacy degree from the University of Illinois in 1978. Following 4 years of community and hospital pharmacy practice, including 2 years on the Pine Ridge Indian Reservation in South Dakota, he completed his graduate education at the University of Kentucky, receiving his Ph.D. degree in toxicology in 1987. Dr. Fudala then spent 4 years at the Addiction Research Center in Baltimore and in 1991 relocated to Philadelphia where he is currently Research Associate Professor of Pharmacology in Psychiatry at the University of Pennsylvania School of Medicine and Clinical Toxicologist at the Veterans Affairs Medical Center. He also serves as Chairman of the Mental Disorders Medications Development Center, part of an interagency medication development effort between NIDA and the U.S. Department of Veterans Affairs. Over the past 15 years Dr. Fudala has conducted numerous clinical trials assessing the safety, efficacy, abuse liability, and pharmacokinetic profiles of buprenorphine and a buprenorphine/naloxone combination product.

<< Back

Mindy Fullilove, M.D.
Professor of Clinical Psychiatry and Public Health
Columbia University
Unit 29
1051 Riverside Drive
New York, NY 10032
(212) 740-7292
(212) 795-4222 Fax

Dr. Fullilove is Professor of Clinical Psychiatry and Public Health at Columbia University. She has studied problems of addiction since 1986, focusing on women's recovery from crack addiction, including comorbidity from trauma, reconnection with their families, and acupuncture as a physiological adjunct. Dr. Fullilove also provides consultation to the Women's Clinic at the Lincoln Recovery Center in the Bronx. She is the author of The House of Joshua: Meditations on Family and Place and is currently working on "Root Shock: The Aftermath of Neighborhood Obliteration."

<< Back

Alexis Gadsden, M.S.W., CASAC
Vice President for Special Projects
Outreach Development Corporation
Outreach Project, Inc.
11711 Myrtle Avenue
Richmond Hill, NY 11418
(718) 847-9233
(718) 849-1093 Fax

Ms. Gadsden is Vice President for Special Projects at the Outreach Development Corporation (Outreach Project, Inc.). She has more than 25 years of experience as a provider of services to special populations and as an administrator of numerous innovative treatment initiatives geared toward addressing the needs of adolescents and women in recovery. Along with Dr. Gadsden's expertise in program development, she has been instrumental in cross-systems collaborations that have supported the creation of local and statewide initiatives focused on systems improvements and best practices for women with children and other special needs populations.

<< Back

Marc Galanter, M.D.
Professor of Psychiatry and Director
Division of Alcoholism and Drug Abuse
New York University School of Medicine
550 First Avenue
New York, NY 10016
(212) 263-6960
(212) 263-8285 Fax

Dr. Galanter is Professor of Psychiatry at New York University (NYU), Founding Director of the Division of Alcoholism and Drug Abuse at NYU and Bellevue Hospital, and Director of the NYU PGY 5-6 Fellowship Program in Addiction Psychiatry. He is also Research Scientist at the Nathan Kline Institute, a World Health Organization Collaborating Center, and Director of the National Center for Medical Fellowships in Alcoholism and Drug Abuse. Dr. Galanter is Editor of the journal Substance Abuse and the annual book series Recent Developments in Alcoholism (Plenum). Among his 246 publications is the text Cults: Faith, Healing and Coercion (Oxford). Dr. Galanter attended the Albert Einstein College of Medicine, where he completed a residency in psychiatry. He then became Clinical Associate at the National Institute of Mental Health, National Institutes of Health (NIH), and then a NIDA/National Institute on Alcohol Abuse and Alcoholism Career Teacher in Alcohol and Drug Abuse. Dr. Galanter later served as President of the Association for Medical Education and Research in Substance Abuse (AMERSA) (1976-1977), American Academy of Addiction Psychiatry (1991-1992), and American Society of Addiction Medicine (1999-2001). His research and teaching interests have focused on addiction treatment and social psychology. Dr. Galanter's NIH- and foundation-funded studies have addressed network therapy for substance abuse, buprenorphine treatment for narcotic addiction, and self-help treatment for substance abusers. From the American Psychiatric Association he received the Gold Achievement Award for innovation in clinical care and the Seymour Vestermark Award for Psychiatric Education; from AMERSA he received the McGovern Award for medical teaching.

View Presentation [PDF format, 76K]

<< Back

Sherri Gillette, M.S., CASAC
Assistant Director and Clinical Supervisor
St. Lawrence Addiction Treatment Center
Hamilton Hall
1 Chimney Point Drive
Ogdensburg, NY 13669
(315) 393-1180, ext. 40

View Presentation [PDF format, 80K]

<< Back

Wayne A. Gordon, Ph.D., ACSW, CASAC
Professor and Associate Director
Department of Rehabilitation Medicine
Mount Sinai School of Medicine
Box 1240
1 Gustave Levy Place
New York, NY 10029-6574
(212) 659-9372
(212) 348-5901 Fax

Dr. Gordon is Professor of Rehabilitation Medicine and Associate Director of the Department of Rehabilitation Medicine at the Mount Sinai School of Medicine. He is also Chief of the Rehabilitation Psychology and Neuropsychology Service. Dr. Gordon is a diplomate in clinical neuropsychology and a fellow of the Academy of Behavioral Medicine Research. He has published more than 100 articles and book chapters. Dr. Gordon is also Project Director of the Research and Training Center on Community Integration of Individuals with Traumatic Brain Injury (TBI). He has received several awards during his career, including a recognition award in 1996 from the New York State Department of Health for "his visionary work" in TBI.

<< Back

Steven J. Grant, Ph.D.
Program Officer
Clinical Neurobiology Branch
Division of Treatment Research and Development
National Institute on Drug Abuse
National Institutes of Health
Neuroscience Center, Room 4238
6001 Executive Boulevard
Bethesda, MD 20892
(301) 443-8869
(301) 443-6814 Fax

Dr. Grant is Program Officer in the Clinical Neurobiology Branch, Division of Treatment Research and Development, NIDA, where he oversees a program in cognitive neuroscience approaches to drug abuse. He has a Ph.D. degree in physiological psychology and a background in neurophysiology, neuropharmacology, and cognitive neuroscience. Prior to joining the NIDA extramural staff, Dr. Grant conducted brain-imaging studies of craving and decisionmaking among drug abusers in the Brain Imaging Center at the NIDA Intramural Research Program.

View Presentation [PDF format, 1.4MB]

<< Back

Perry N. Halkitis, Ph.D.
Assistant Professor
Department of Applied Psychology
Center for HIV/AIDS Educational Studies and Training
New York University
Room East 537G
239 Greene Street
New York, NY 10003
(212) 998-5373
(212) 995-4358 Fax

Dr. Halkitis is Assistant Professor in the Department of Applied Psychology at New York University (NYU) and Co-Director of the Center for HIV/AIDS Educational Studies and Training, an NYU HIV Behavioral Research Center. He is also Principal Investigator of the Protease Inhibitor Longitudinal Life Study (Project PILLS), funded between 1999 and 2003 by NIDA, and Principal Investigator of the Club Drug Men's Health Study (Project BUMPS), funded by NIDA between 2000 and 2004. In addition, Dr. Halkitis is Co-Principal Investigator of the Seropositive Urban Men's Study and Intervention Trial, funded by the Centers for Disease Control and Prevention, as well as Positive Choices, an intervention for alcohol-using HIV-positive men, funded by the National Institute on Alcohol Abuse and Alcoholism. Most recently, as a member of the NYU Medical School Center for AIDS Research, he is undertaking an investigation of HIV genetic resistance among gay and bisexual men (Project RADAR) as well as the impact of antidepressants on sexual risk-taking among drug-using gay men. In 1998 Dr. Halkitis was funded as Principal Investigator by the American Psychological Foundation to examine the emergence of methamphetamine use in New York City (Project Tina). He has a B.A. degree in biology and psychology from Columbia University, a master's degree in teaching and learning from Hunter College, City University of New York, a master's degree in educational psychology, and a Ph.D. degree in quantitative methods from the Graduate Center, City University of New York.

View Presentation [PDF format, 116K]

<< Back

Margaret Haney, Ph.D.
Assistant Professor of Clinical Behavioral Biology
College of Physicians and Surgeons
Research Scientist V
New York State Psychiatric Institute
Columbia University
Suite 120
1051 Riverside Drive
New York, NY 10032
(212) 543-6539
(212) 543-5991 Fax

Dr. Haney is an experimental psychologist who has been studying the effects of drugs of abuse for more than 15 years. She is Assistant Professor of Clinical Behavioral Biology in the Department of Psychiatry at the College of Physicians and Surgeons of Columbia University and Research Scientist V at the New York State Psychiatric Institute. Dr. Haney's recent work includes (1) characterizing marijuana dependence under controlled laboratory conditions and exploring potential pharmacotherapy for marijuana treatment, (2) investigating the role of endogenous opioids in mediating marijuana's reinforcing and subjective effects, and (3) comparing smoked marijuana and oral THC in the treatment of HIV.

<< Back

Glen R. Hanson, Ph.D., D.D.S.
Acting Director
National Institute on Drug Abuse
National Institutes of Health
Neuroscience Center, Room 5274
MSC 9581
6001 Executive Boulevard
Bethesda, MD 20892-9581
(301) 443-6480
(301) 443-9127 Fax

On November 30, 2001, Dr. Hanson was named Acting Director of NIDA by Ruth Kirschstein, M.D., Acting Director of the National Institutes of Health (NIH), and assumed his duties on December 1, 2001. Dr. Hanson is an internationally recognized expert on psychostimulants. He is particularly well known for his work on the neurotoxic properties of Ecstasy (MDMA) and amphetamines and the role of brain peptides in psychiatric and neurological functions. Dr. Hanson has been supported by research grants from NIDA and the National Institute of Mental Health since the early 1980s and in 1998 received a Senior Scientist Award from NIDA. He has served on several NIH grant review committees and on the editorial board of the Journal of Pharmacology and Experimental Therapeutics. Dr. Hanson is a frequent reviewer of most of the major pharmacology and neuroscience journals. He joined NIDA in September 2000 as Director of NIDA's Division of Neuroscience and Behavioral Research. Dr. Hanson is also Professor in the University of Utah's Department of Pharmacology and Toxicology and obtained his D.D.S. degree from the University of California, Los Angeles, and his Ph.D. degree from the University of Utah. From 1978 to 1980 he was a fellow in the NIH Pharmacology Research Associates Training Program. NIDA is a component of NIH, U.S. Department of Health and Human Services. The Institute supports more than 85 percent of the world's research on the health aspects of drug abuse and addiction and carries out a large variety of programs to ensure the rapid and effective dissemination and use of research results to improve drug abuse, prevention, treatment, and policy.

<< Back

Deborah Hasin, Ph.D.
Professor of Clinical Public Health
Columbia University
Box 123
1051 Riverside Drive
New York, NY 10032
(212) 543-5518
(212) 543-5386 Fax

Dr. Hasin is Professor of Clinical Public Health in the School of Public Health and the College of Physicians and Surgeons at Columbia University. She has extensive experience in conducting longitudinal studies of the course of alcohol and other drug problems in treated and untreated individuals. Dr. Hasin has also studied the effects of comorbidity on the outcome of alcohol and other drug dependence and the reliability and validity of measures of substance dependence and abuse. Much of her research has taken place in the United States, but she has also collaborated on international projects, including studies on alcohol and other drugs with the World Health Organization and alcohol studies in Israel. Dr. Hasin holds a master's degree in social work and a doctorate in epidemiology. She and members of her research team provide training and technical assistance to single-site and multisite studies in the United States and abroad.

<< Back

Denise Hien, Ph.D.
Women's Health Project Treatment and Research Center
Associate Professor in Psychology
Columbia University School of Social Work
St. Luke's-Roosevelt Hospital Center
Room 3B
411 West 114th Street
New York, NY 10025
(212) 523-4853
(212) 523-2140 Fax

Dr. Hien is Associate Professor in Psychology at the Derner Institute of Advanced Psychological Studies, Adelphi University, and Lecturer in Psychiatry at the Columbia University College of Physicians and Surgeons. She is also Executive Director of the Women's Health Project Treatment and Research Center at St. Luke's-Roosevelt Hospital Center and Principal Investigator and recipient of numerous NIDA-funded studies. These studies investigate links between interpersonal violence and cocaine use disorders among inner-city women and test the efficacy of specialized treatments for trauma and addiction. She has also received a National Institutes of Health (NIH) Office of Research on Women's Health Supplemental grant and is a mentor to predoctoral students with National Research Service Awards. Dr. Hien has 15 years of clinical experience, with predoctoral and postdoctoral specializations in child and adolescent psychology as well as in addictions. She has 13 years of clinical research experience, largely focused on diagnostic and treatment issues in women's health and violence. Dr. Hien is a nationally recognized expert in the study of women, violence, and drug abuse. She has authored numerous peer-reviewed journal articles and book chapters and has given presentations at national international conferences. The Women's Health Project Treatment and Research Center at St. Luke's-Roosevelt Hospital Center was founded in 1994 to further the study of the occurrence and treatments of interpersonal violence in the lives of inner-city women. This project is entirely funded by competitively earned NIH and NIDA grants to Dr. Hien. The major health-related goals of the Women's Health Project are to conduct epidemiological studies on the risk factors of violence by females - both as victims and as perpetrators of child abuse and neglect. The project includes psychotherapy intervention studies that examine treatment efficacy for women with posttraumatic stress disorder and drug abuse.

<< Back

Terry Horton, M.D.
Medical Director and Vice President
Phoenix House Foundation, Inc.
164 74th Street
New York, NY 10023
(212) 595-5810, ext. 7901
(212) 496-6035 Fax

Dr. Horton is Medical Director and Vice President of Phoenix House Foundation, Inc., one of the Nation's largest substance abuse treatment and prevention agencies, serving more than 5,000 clients in 8 States. He is a practicing internist and has devoted his career to providing primary health care to substance abusers, detainees, and other underserved populations. In New York Dr. Horton has developed and manages a primary care program that provides onsite medical, dental, psychiatric, optometric, and HIV services. His interests are community-based detoxification and the interface of substance abuse and primary health care. In addition, Dr. Horton and his staff teach medical students, dentists, and addiction medicine fellows through affiliations with Weill Medical College at Cornell University, New York Medical College, and Columbia University. He serves on the New York State Office of Alcoholism and Substance Abuse Services Medical Advisory Panel and on the Delaware Governor's Council on Alcohol, Substance Abuse, and Mental Health. Dr. Horton is a member of the American College of Physicians, American Society of Addiction Medicine, and Delaware Academy of Medicine.

View Presentation [PDF format, 200K]

<< Back

Robert L. Hubbard, Ph.D., M.B.A.
Adjunct Professor
Department of Psychiatry and Behavioral Sciences
Duke University Medical Center
North Carolina Office
National Development and Research Institutes, Inc.
Suite 140
940 Main Campus Drive
Raleigh, NC 27606
(919) 863-4600, ext. 229
(919) 863-4601 Fax

Dr. Hubbard is Director of the North Carolina Office of the National Development and Research Institutes, Inc. (NDRI-NC), which focuses exclusively on drug abuse treatment research. He is also Principal Investigator of the Drug Abuse Treatment Outcome Study (DATOS), an ongoing national study of drug abuse treatment, and has been Principal Investigator of the Treatment Outcome Prospective Study (TOPS), an earlier study initiated in 1976. In addition, Dr. Hubbard is Principal Investigator of the North Carolina Node of the NIDA Clinical Trials Network and directs the development and implementation of the North Carolina Treatment Outcome and Program Performance System. His career has been committed to the advancement of science in the drug abuse treatment research field. Dr. Hubbard and his colleagues authored the book Drug Abuse Treatment: A National Study of Effectiveness (University of North Carolina Press, 1989) as well as numerous reports of studies of alcohol and other drug abuse and research methodology. He served on the Institute of Medicine Committee on Substance Abuse Treatment Coverage and on the National Research Council Panel on the Evaluation of AIDS Interventions. Dr. Hubbard is a member of the board of directors of the North Carolina Governor's Institute on Alcohol & Substance Abuse, Inc. He is an acknowledged expert on alcohol and other drug abuse survey research methodology, research design, and methods of validating self-reports. Dr. Hubbard has formal training and considerable experience in psychometric theory, field-based randomized clinical trial designs, survey research design, multivariate statistical analysis, and qualitative case study approaches. Throughout his career, he has worked closely with major investigators in the field in collaborative efforts to understand drug abuse and its prevention and treatment and to develop more appropriate ways to demonstrate the effects of substance abuse.

<< Back

Drew Humphries, Ph.D.
Professor of Sociology
Rutgers University
311 North Fifth Street
Camden, NJ 08102-1405
(856) 225-6073
(856) 225-6602 Fax

Dr. Humphries recently received an Addictions Research, Education, and Practice Award from the Northeastern States Addiction Technology Transfer Center, which is funded through the Substance Abuse and Mental Health Services Administration's Center for Substance Abuse Treatment. Her project blended addiction knowledge and teacher training to help elementary school teachers provide appropriate social and academic support for children who may be affected by caregiver addiction. An academic by training, Dr. Humphries is Director of Criminal Justice and Associate at the Center for Children and Childhood Studies at Rutgers University. She has more than 20 years of teaching experience in the area of drugs and women and crime, among others. Drugs, women, and children are also themes addressed in Dr. Humphries' 1999 book Crack Mothers: Pregnancy, Drugs, and the Media (Ohio State University Press), which looks at social reactions to maternal drug use. Her ongoing research focuses on drug courts and the role of treatment on the quality of life of children in families affected by alcohol or other drug dependence.

View Presentation [PDF format, 212K]

<< Back

What's New Contents

Blending Conference Bridge Logo

Sponsored by
National Institute on Drug Abuse
National Institutes of Health
Department of Health and Human Services

In partnership with
The New York CTN Node/New York University School of Medicine
The Long Island CTN Node/Columbia University and New York State Psychiatric Institute
New York State Office of Alcoholism and Substance Abuse Services
Alcoholism and Substance Abuse Providers of NYS
Northeast Addiction Technology Transfer Center (ATTC)
New York State Practice Improvement Collaborative (PIC)

Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal